Live Breaking News & Updates on Miltenyi Biomedicine|Page 2

Stay updated with breaking news from Miltenyi biomedicine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Zamtocabtagene Autoleucel Produces High ORR in Relapsed/Refractory DLBCL

Zamtocabtagene autoleucel produced responses in patients with relapsed/refractory diffuse large B-cell lymphoma in a phase 2 trial. ....

Bristol Myers Squibb Juno , Niravn Shah , College Of Wisconsin , Tandem Meetings , Medical College , Miltenyi Biomedicine , Legend Biotech , Kite Pharma , Seattle Genetics ,